Madrigal Pharmaceuticals(MDGL) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates CONSHOHOCKEN, Pa., May 7, 2024 – Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH), today reports first-quarter 2024 financial results and provides corporate updates. Bill Sibold, Chief Executive Officer of Madrigal, stated, "Madrigal is the first company to deliver an approved therapy for pa ...